Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

As Vertex broadens remit, Leiden handing baton to Kewalramani

July 25, 2019 8:51 PM UTC

As Vertex continues to push its pipeline beyond cystic fibrosis, it will do so with a new president and CEO at the helm.

Chairman, President and CEO Jeffrey Leiden will step down from his position on April 1, 2020, to become executive chairman, and Reshma Kewalramani will take over as president and CEO. She is CMO and the company's EVP, global medicines development and medical affairs...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Vertex Pharmaceuticals Inc.